263550-60-3 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 6-bromo-4,4-dimethyl-3,4-dihydroquinoline-1(2H)-carboxylate serves as an intermediate in the synthesis of various pharmaceutical compounds due to its unique chemical properties. It is particularly valuable in medicinal chemistry research and drug development, where its structure can be modified to create new therapeutic agents with specific biological activities.
Used in Chemical Industry:
In the chemical industry, tert-butyl 6-bromo-4,4-dimethyl-3,4-dihydroquinoline-1(2H)-carboxylate is employed as a building block for the creation of complex organic molecules. Its reactivity and structural features make it suitable for use in the synthesis of specialty chemicals, agrochemicals, and other related products.
Used in Medicinal Chemistry Research:
As a compound with potential biological activities, tert-butyl 6-bromo-4,4-dimethyl-3,4-dihydroquinoline-1(2H)-carboxylate is utilized in medicinal chemistry research to explore its interactions with biological targets. This research can lead to the discovery of new drugs or the optimization of existing ones, enhancing their efficacy and safety profiles.
Used in Drug Development:
In drug development, tert-butyl 6-bromo-4,4-dimethyl-3,4-dihydroquinoline-1(2H)-carboxylate is employed as a starting material or a key intermediate in the synthesis of new drug candidates. Its unique structure allows for the design of molecules with specific pharmacological properties, contributing to the advancement of novel therapeutic agents for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 263550-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,5,5 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 263550-60:
(8*2)+(7*6)+(6*3)+(5*5)+(4*5)+(3*0)+(2*6)+(1*0)=133
133 % 10 = 3
So 263550-60-3 is a valid CAS Registry Number.
263550-60-3Relevant articles and documents
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells
Gnanasekaran, Krishna Kumar,Pouland, Tim,Bunce, Richard A.,Darrell Berlin,Abuskhuna, Suaad,Bhandari, Dipendra,Mashayekhi, Maryam,Zhou, Donghua H.,Benbrook, Doris M.
, (2019/12/24)
SHetA2 (NSC 721689), our lead Flex-Het anti-cancer agent, consists of a thiochroman (Ring A) and a 4-nitrophenyl (Ring B) linked by a thiourea bridge. In this work, several series of new analogs having a tetrahydroquinoline (THQ, Ring A) unit connected by
CHROMAN-SUBSTITUTED, TETRAHYDROQUINOLINE-SUBSTITUTED AND THIOCHROMAN-SUBSTITUTED HETEROAROTINOIDS AS ANTI-CANCER AGENTS
-
Paragraph 0221; 0226; 0241; 0320, (2020/03/09)
Chemical compounds that inhibit cancer cell growth are provided. The compounds are heteroarotinoids and derivatives thereof with oxygen, nitrogen or sulfur in chroman systems, tetrahydroquinoline systems, and tetrahydrothiochroman systems.
